Meet Tru-D: First to Market, Still Leading the Way
As CEO of Tru-D SmartUVC, I’ve been in the UV disinfection industry most of my career. In the early days, it was primarily in upper air UV applications and HVAC systems. The disinfecting power of properly-dosed UVC has always amazed me. When Tru-D SmartUVC was brought to the table in 2007, I knew that it had the ability to change the way health care works by providing a cleaner, safer environment for patients and staff.
Since that time, notable researchers and prestigious health systems have conducted independent research on our product to prove its effectiveness in reducing the risk of infection of major superbugs not only from patient to patient, but also facility-wide. Now with more than 15 studies backing our product, we are more confident than ever that Tru-D will become a standard of care throughout the health care industry.
Tru-D placed the first UVC robot in a health care facility in 2007, and that first unit sold is still in operation today. Our product is now deployed in hundreds of hospitals throughout the U.S. and is validated by the only randomized clinical trial on UVC disinfection which was funded by the CDC. Over the next few weeks, we will be sharing details on the randomized clinical trial, its results as well as our programmatic, bundled approach to infection prevention.
I hope you read along throughout this blog series and find the information useful to take back to your facility. If you have questions or would like more information, please e-mail firstname.lastname@example.org.